35 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
TMO Thermo Fisher Scientific Inc $238.46 $96.05B N/A
Article Searches
Thermo Fisher Scientific Inc.'s (TMO) CEO Marc Casper on Q1 2020 Results - Earnings Call Transcript https://seekingalpha.com/article/4339175-thermo-fisher-scientific-inc-s-tmo-ceo-marc-casper-on-q1-2020-results-earnings-call?source=feed_sector_healthcare Apr 22, 2020 - Thermo Fisher Scientific Inc. (NYSE:TMO) Q1 2020 Results Earnings Conference Call April 22, 2020, 08:30 AM ET Company Participants Kenneth Apicerno - Vice President-Investor Relations Marc Casper - Ch
Thermo Fisher Scientific Inc (TMO) Q1 2020 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/04/22/thermo-fisher-scientific-inc-tmo-q1-2020-earnings.aspx?source=iedfolrf0000001 Apr 22, 2020 - TMO earnings call for the period ending March 28, 2020.
Here's How Thermo Fisher Scientific Beat Wall Street Expectations in Q1 https://www.fool.com/investing/2020/04/22/heres-how-thermo-fisher-scientific-beat-wall-stree.aspx?source=iedfolrf0000001 Apr 22, 2020 - The healthcare giant's COVID-19 efforts are helping it weather the storm.
FDA EUA for Coronavirus Tests Boosts MedTech: 3 Stocks in Focus http://www.zacks.com/stock/news/838283/fda-eua-for-coronavirus-tests-boosts-medtech-3-stocks-in-focus?cid=CS-ZC-FT-analyst_blog|industry_focus-838283 Mar 27, 2020 - These key biotech and molecular diagnostic players banking on the receipt of FDA's EUA for COVID-19 tests are currently outperforming the broader industries they belong to.
Healthcare Stocks & ETFs to Gain on Coronavirus Test Progress http://www.zacks.com/stock/news/857565/healthcare-stocks-etfs-to-gain-on-coronavirus-test-progress?cid=CS-ZC-FT-etf_news_and_commentary-857565 Apr 06, 2020 - It seems that testing for COVID-19 is the major key in controlling the outbreak and helps in making decisions like treatment protocols, resource allocation and drafting the right healthcare policies.
Here's Why You Should Hold on to Thermo Fisher (TMO) for Now http://www.zacks.com/stock/news/858878/heres-why-you-should-hold-on-to-thermo-fisher-tmo-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-858878 Apr 07, 2020 - Investors continue to be optimistic about Thermo Fisher (TMO) on its strong segmental growth in the fourth quarter of 2019.
Analysts Estimate Thermo Fisher Scientific (TMO) to Report a Decline in Earnings: What to Look Out for http://www.zacks.com/stock/news/872603/analysts-estimate-thermo-fisher-scientific-tmo-to-report-a-decline-in-earnings-what-to-look-out-for?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_9-872603 Apr 15, 2020 - Thermo Fisher (TMO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PRA Health (PRAH) Inks Deal With Leukemia & Lymphoma Society http://www.zacks.com/stock/news/1055339/pra-health-prah-inks-deal-with-leukemia-lymphoma-society?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1055339 Sep 09, 2020 - PRA Health (PRAH) partners with LLS to bring new treatments for children with relapsed acute leukemia.
Here's Why You Should Hold on to Medtronic Stock for Now http://www.zacks.com/stock/news/1057902/heres-why-you-should-hold-on-to-medtronic-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-1057902 Sep 14, 2020 - Investors continue to be optimistic about Medtronic (MDT) on robust segmental growth and strong ventilators sales.
National Vision Banks on Contact Lens Sales Amid Coronavirus Woes http://www.zacks.com/stock/news/1057927/national-vision-banks-on-contact-lens-sales-amid-coronavirus-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-1057927 Sep 14, 2020 - National Vision (EYE) sales bear the impact of unfavorable timing of unearned revenues.

Pages: 1234

Page 1>